红日药业：关于持股5%以上的股东、公司部分高级管理人员减持股份预披露公告

Core Points - Hongri Pharmaceutical announced that shareholder Mr. Yao Xiaoqing plans to reduce his holdings by up to 46,936,332 shares, representing 1.5624% of the total share capital, within three months after a 15-trading-day period following the announcement [2] - Senior management personnel Mr. Chen Ruiqiang intends to sell up to 169,000 shares, accounting for 0.0056% of the total share capital, also within the same timeframe [2] - Another senior management member, Mr. Zhang Kun, plans to reduce his holdings by up to 232,000 shares, which is 0.0077% of the total share capital, within the specified period [2]